Agilent TechnologiesFRA:AG8 -0.25%91 Net Margin % is 18.47% as of Apr. 2026, which is 1% above its 10-year median of 18.23. GuruFocus rates FRA:AG8 with a GF Score™ of 91/100 and a GF Value™ of €127.48 (Fairly Valued). The stock has 1 warning sign investors should review. Among 204 Medical Diagnostics & Research companies, Agilent Technologies ranks better than 92.16% on this metric.
The historical rank and industry rank for Agilent Technologies's Net Margin % or its related term are showing as below:
FRA:AG8'
s Net Margin % Range Over the Past 10 Years
Min: 6.43 Med: 18.23 Max: 20.74
Current: 19.55
FRA:AG8's Net Margin % is ranked better than 92.16% of 204
companies
in the Medical Diagnostics & Research industry
Industry Median: -2.405
vs FRA:AG8: 19.55
Agilent Technologies (FRA:AG8) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Agilent Technologies Net Margin % Related Terms
Agilent Technologies Net Margin % Historical Data
* Premium members only.
The historical data trend for Agilent Technologies's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:AG8 vs WAT, IDXX, NTRA: Net Margin % Comparison
For the Diagnostics & Research subindustry, Agilent Technologies's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Agilent Technologies Net Margin % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Agilent Technologies's Net Margin % distribution charts can be found below:
* The bar in red indicates where Agilent Technologies's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Agilent Technologies (FRA:AG8) has a Net Margin % of 18.47% as of Apr. 2026. Net margin is the ratio of total net income to net sales. View historical data on Agilent Technologies and its competitors. This is near median its historical median of 18.23. Over the past decade, Agilent Technologies' Net Margin % has ranged from 6.43 to 20.74. According to the industry distribution chart, Agilent Technologies ranks #16 out of 204 companies in the Medical Diagnostics & Research industry, placing it in the top 7.8%.
Is Agilent Technologies' Net Margin % too high?
Agilent Technologies' current Net Margin % of 18.47% is near median its 10-year median of 18.23. Over the past 10 years, this metric has ranged from a low of 6.43 to a high of 20.74. Based on the distribution chart, Agilent Technologies ranks #16 out of 204 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Agilent Technologies has a GF Score™ of 91/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Agilent Technologies' Net Margin % compare to WAT and IDXX?
According to the Medical Diagnostics & Research industry distribution chart, Agilent Technologies ranks #16 out of 204 companies for Net Margin %. This places Agilent Technologies in the top 8% of its industry — outperforming the majority of peers. Historically, Agilent Technologies' own Net Margin % has ranged from 6.43 to 20.74 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Diagnostics & Research company?
A good Net Margin % depends on the Medical Diagnostics & Research industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Agilent Technologies and its competitors. Agilent Technologies's current Net Margin % is 18.47%, which is near median its own 10-year median of 18.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Agilent Technologies stock overvalued right now?
Based on GuruFocus' analysis, Agilent Technologies (FRA:AG8) is currently considered Fairly Valued. The stock's GF Value™ is €127.48, compared to a current price of €119.35 — trading 6.4% below its estimated fair value. The current Net Margin % is 18.47%, which is near median its 10-year median of 18.23. Agilent Technologies' overall GF Score™ is 91/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Agilent Technologies (FRA:AG8), the current Net Margin % is 18.47% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Agilent Technologies (FRA:AG8) Overvalued in 2026?
Based on GuruFocus' analysis, Agilent Technologies stock appears to be undervalued.
The current stock price of €119.35 is trading 6.4% below its estimated GF Value™ of €127.48.
GuruFocus considers Agilent Technologies to be Fairly Valued.
Key valuation signals for FRA:AG8:
Net Margin %: 18.47% (near median its 10-year median of 18.23)
GF Value™: €127.48 vs. price of €119.35 (6.4% below fair value)
No single metric tells the full story. See the FRA:AG8 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and diagnostics, cross lab operations consisting of consumables and services, and applied end markets. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.
91GF Score
Get the complete analysis for FRA:AG8
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:AG8 has been successfully added to your 
